Ying Cai

1.0k total citations · 1 hit paper
10 papers, 786 citations indexed

About

Ying Cai is a scholar working on Materials Chemistry, Biomedical Engineering and Toxicology. According to data from OpenAlex, Ying Cai has authored 10 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Materials Chemistry, 3 papers in Biomedical Engineering and 2 papers in Toxicology. Recurrent topics in Ying Cai's work include Advanced Nanomaterials in Catalysis (3 papers), Nanoplatforms for cancer theranostics (3 papers) and Pharmacovigilance and Adverse Drug Reactions (2 papers). Ying Cai is often cited by papers focused on Advanced Nanomaterials in Catalysis (3 papers), Nanoplatforms for cancer theranostics (3 papers) and Pharmacovigilance and Adverse Drug Reactions (2 papers). Ying Cai collaborates with scholars based in China and United States. Ying Cai's co-authors include Sampath Parthasarathy, Susan D. Moffatt‐Bruce, Robert D. Brook, Michael C. Ostrowski, Lung‐Chi Chen, Qinghua Sun, Carey N. Lumeng, Thomas Kampfrath, Peibin Yue and Jeffrey A. Deiuliis and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Ying Cai

7 papers receiving 769 citations

Hit Papers

Ambient Air Pollution Exaggerates Adipose Inflammation an... 2009 2026 2014 2020 2009 200 400 600

Peers

Ying Cai
Catherine A. Shaw United Kingdom
Lori A. Bramble United States
Steven G. McLean United Kingdom
Luis A. Jiménez United Kingdom
Donald S. Anderson United States
Thomas C. Donaghey United States
Catherine A. Shaw United Kingdom
Ying Cai
Citations per year, relative to Ying Cai Ying Cai (= 1×) peers Catherine A. Shaw

Countries citing papers authored by Ying Cai

Since Specialization
Citations

This map shows the geographic impact of Ying Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Cai more than expected).

Fields of papers citing papers by Ying Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Cai. The network helps show where Ying Cai may publish in the future.

Co-authorship network of co-authors of Ying Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Cai. A scholar is included among the top collaborators of Ying Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Cai. Ying Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Cai, Ying, et al.. (2025). Adverse events reporting of Etelcalcetide: a real-word analysis from FAERS database. Journal of Pharmaceutical Policy and Practice. 18(1). 2479072–2479072.
3.
Zhang, Yueyang, Ying Chen, Bo Wang, et al.. (2024). A novel selenium nanocomposite modified by AANL inhibits tumor growth by upregulating CLK2 in lung cancer. Bioorganic Chemistry. 148. 107459–107459. 4 indexed citations
4.
Cai, Ying, et al.. (2024). A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System. Frontiers in Pharmacology. 15. 1442765–1442765. 1 indexed citations
5.
Lin, Jia-Yin, Xiaofeng Fan, Yue Guo, et al.. (2021). Shining light on chiral inorganic nanomaterials for biological issues. Theranostics. 11(19). 9262–9295. 46 indexed citations
6.
Miao, Jun, Ying Cai, Huiyu Huang, et al.. (2021). Multiple cell death pathways triggered by temperature-mediated synergistic effect derived from chiral phototheranostic ablation nanoagents. Applied Materials Today. 23. 101001–101001. 11 indexed citations
7.
Li, Yiwen, et al.. (2019). A Visible‐ and NIR‐Light Responsive Photothermal Therapy Agent by Chirality‐Dependent MoO3−x Nanoparticles. Advanced Functional Materials. 30(4). 101 indexed citations
8.
Zhang, Xing, Ying Shen, Ying Cai, et al.. (2018). GW29-e1093 Factors Influencing Hypertensive’s Salt-Reduction Behavior: A Qualitative Study Guided by Health Belief Model. Journal of the American College of Cardiology. 72(16). C229–C230.
9.
Liu, Shiwei, Yuling Hong, Quanhe Yang, et al.. (2015). Cardiovascular disease deaths and high sodium consumption in Shandong province and China: a modelling analysis. The Lancet. 386. S80–S80. 4 indexed citations
10.
Sun, Qinghua, Peibin Yue, Jeffrey A. Deiuliis, et al.. (2009). Ambient Air Pollution Exaggerates Adipose Inflammation and Insulin Resistance in a Mouse Model of Diet-Induced Obesity. Circulation. 119(4). 538–546. 619 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026